{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:51:17Z","timestamp":1784029877391,"version":"3.55.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"Supplement_7","funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N91019D00024"],"award-info":[{"award-number":["75N91019D00024"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Although there are now approved treatments and vaccines for Ebola virus disease, the case fatality rate remains unacceptably high even when patients are treated with the newly approved therapeutics. Furthermore, these countermeasures are not expected to be effective against disease caused by other filoviruses. A meeting of subject-matter experts was held during the 10th International Filovirus Symposium to discuss strategies to address these gaps. Several investigational therapeutics, vaccine candidates, and combination strategies were presented. The greatest challenge was identified to be the implementation of well-designed clinical trials of safety and efficacy during filovirus disease outbreaks. Preparing for this will require agreed-upon common protocols for trials intended to bridge multiple outbreaks across all at-risk countries. A multinational research consortium including at-risk countries would be an ideal mechanism to negotiate agreement on protocol design and coordinate preparation. Discussion participants recommended a follow-up meeting be held in Africa to establish such a consortium.<\/jats:p>","DOI":"10.1093\/infdis\/jiad354","type":"journal-article","created":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T08:10:53Z","timestamp":1692432653000},"page":"S474-S478","source":"Crossref","is-referenced-by-count":7,"title":["Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting"],"prefix":"10.1093","volume":"228","author":[{"given":"Armand","family":"Sprecher","sequence":"first","affiliation":[{"name":"M\u00e9decins Sans Fronti\u00e8res , Brussels , Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Cross","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch , Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0186-9587","authenticated-orcid":false,"given":"Andrea","family":"Marzi","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Hamilton, Montana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen A","family":"Martins","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, US Department of Health and Human Services , Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Wolfe","sequence":"additional","affiliation":[{"name":"Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, US Department of Health and Human Services , Washington, District of Columbia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0523-4431","authenticated-orcid":false,"given":"Joel M","family":"Montgomery","sequence":"additional","affiliation":[{"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina F","family":"Spiropoulou","sequence":"additional","affiliation":[{"name":"Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Cihlar","sequence":"additional","affiliation":[{"name":"Gilead Sciences Inc , Foster City, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Ahuka-Mundeke","sequence":"additional","affiliation":[{"name":"Institut National de Recherche Biom\u00e9dicale , Kinshasa, Republic of the Congo"},{"name":"Kinshasa Teaching Hospital, School of Medicine, Kinshasa University , Democratic Republic of the Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Nyhuis","sequence":"additional","affiliation":[{"name":"Mapp Biopharmaceutical, Inc , San Diego, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie","family":"Teicher","sequence":"additional","affiliation":[{"name":"M\u00e9decins Sans Fronti\u00e8res , New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Crozier","sequence":"additional","affiliation":[{"name":"Clinical Monitoring Program Research Directorate, Frederick National Laboratory for Cancer Research , Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Strong","sequence":"additional","affiliation":[{"name":"Special Pathogens Program, National Microbiology Laboratory Branch, Public Health Agency of Canada"},{"name":"Department of Medical Microbiology and Infectious Diseases, University of Manitoba , Winnipeg"},{"name":"Department of Pediatrics and Child Health, University of Manitoba , Winnipeg"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Kobinger","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch , Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Woolsey","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch , Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W","family":"Geisbert","sequence":"additional","affiliation":[{"name":"Galveston National Laboratory, University of Texas Medical Branch , Galveston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9448-8227","authenticated-orcid":false,"given":"Heinz","family":"Feldmann","sequence":"additional","affiliation":[{"name":"Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health , Hamilton, Montana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Muyembe","sequence":"additional","affiliation":[{"name":"Institut National de Recherche Biom\u00e9dicale , Kinshasa, Republic of the Congo"},{"name":"Kinshasa Teaching Hospital, School of Medicine, Kinshasa University , Democratic Republic of the Congo"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,8,19]]},"reference":[{"key":"2023111521055128000_jiad354-B1","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2023111521055128000_jiad354-B2","author":"Centers for Disease Control and Prevention","year":"2023"},{"key":"2023111521055128000_jiad354-B3","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1056\/NEJMoa1910993","article-title":"A randomized, controlled trial of Ebola virus disease therapeutics","volume":"381","author":"Mulangu","year":"2019","journal-title":"N Engl J Med"},{"key":"2023111521055128000_jiad354-B4","doi-asserted-by":"crossref","first-page":"e835","DOI":"10.1093\/cid\/ciac732","article-title":"Post-Ebola symptoms 7 years after infection: the natural history of long Ebola","volume":"76","author":"Wohl","year":"2023","journal-title":"Clin Infect Dis"},{"key":"2023111521055128000_jiad354-B5","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1093\/cid\/ciab215","article-title":"PREVAIL IV: a randomized, double-blind, 2-phase, phase 2 trial of remdesivir vs placebo for reduction of Ebola virus RNA in the semen of male survivors","volume":"73","author":"Higgs","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2023111521055128000_jiad354-B6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/vaccines9030190","article-title":"Development of pandemic vaccines: ERVEBO case study","volume":"9","author":"Wolf","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"2023111521055128000_jiad354-B7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.chom.2018.12.005","article-title":"A two-antibody pan-ebolavirus cocktail confers broad therapeutic protection in ferrets and nonhuman primates","volume":"25","author":"Bornholdt","year":"2019","journal-title":"Cell Host Microbe"},{"key":"2023111521055128000_jiad354-B8","doi-asserted-by":"crossref","first-page":"eaai8711","DOI":"10.1126\/scitranslmed.aai8711","article-title":"Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody","volume":"9","author":"Mire","year":"2017","journal-title":"Sci Transl Med"},{"key":"2023111521055128000_jiad354-B9","author":"International AIDS Vaccine Initiative","year":"2022"},{"key":"2023111521055128000_jiad354-B10","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3390\/vaccines10101582","article-title":"Nonhuman primates are protected against Marburg virus disease by vaccination with a vesicular stomatitis virus vector\u2013based vaccine prepared under conditions to allow advancement to human clinical trials","volume":"10","author":"Cooper","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2023111521055128000_jiad354-B11","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3390\/vaccines10071004","article-title":"A cloned recombinant vesicular stomatitis virus\u2013vectored Marburg vaccine, PHV01, protects guinea pigs from lethal Marburg virus disease","volume":"10","author":"Zhu","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2023111521055128000_jiad354-B12","first-page":"91","volume-title":"NPJ Vaccines","author":"Cao","year":"2023"},{"key":"2023111521055128000_jiad354-B13","doi-asserted-by":"crossref","first-page":"e171","DOI":"10.1016\/S2666-5247(23)00001-0","article-title":"Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus\u2013based Sudan virus vaccine: a challenge study in macaques","volume":"4","author":"Marzi","year":"2023","journal-title":"Lancet Microbe"},{"key":"2023111521055128000_jiad354-B14","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3390\/vaccines10111935","article-title":"Single-shot ChAd3-MARV vaccine in modified formulation buffer shows 100% protection of NHPs","volume":"10","author":"Finch","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"2023111521055128000_jiad354-B15","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiad157","article-title":"A highly attenuated panfilovirus VesiculoVax vaccine rapidly protects nonhuman primates against Marburg virus and 3 species of Ebola virus","volume":"228","author":"Woolsey","year":"2023","journal-title":"J Infect Dis"},{"key":"2023111521055128000_jiad354-B16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrd.2017.251","article-title":"Post-exposure treatments for Ebola and Marburg virus infections","volume":"17","author":"Cross","year":"2018","journal-title":"Nat Rev Drug Discov"},{"key":"2023111521055128000_jiad354-B17","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(16)32621-6","article-title":"Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola \u00c7a Suffit!)","volume":"389","author":"Henao-Restrepo","year":"2017","journal-title":"Lancet"},{"key":"2023111521055128000_jiad354-B18","doi-asserted-by":"publisher","first-page":"S1473-3099(23)00344-4","DOI":"10.1016\/S1473-3099(23)00344-4","article-title":"Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial","author":"Mwesigwa","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"2023111521055128000_jiad354-B19","doi-asserted-by":"crossref","first-page":"e159090","DOI":"10.1172\/jci.insight.159090","article-title":"Combination therapy with remdesivir and monoclonal antibodies protects nonhuman primates against advanced Sudan virus disease","volume":"7","author":"Cross","year":"2022","journal-title":"JCI Insight"},{"key":"2023111521055128000_jiad354-B20","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/s41467-021-22132-0","article-title":"Combination therapy protects macaques against advanced Marburg virus disease","volume":"12","author":"Cross","year":"2021","journal-title":"Nat Commun"},{"key":"2023111521055128000_jiad354-B21","first-page":"1891.","volume-title":"J Med Chem","author":"Mackman","year":"2023"},{"key":"2023111521055128000_jiad354-B22","author":"Anoshchenko"},{"key":"2023111521055128000_jiad354-B23","author":"Gilead Sciences","year":"2023"},{"key":"2023111521055128000_jiad354-B24","author":"Gilead Sciences","year":"2023"},{"key":"2023111521055128000_jiad354-B25","author":"US Embassy in Uganda","year":"2022"},{"key":"2023111521055128000_jiad354-B26","author":"World Health Organization","year":"2022"},{"key":"2023111521055128000_jiad354-B27","author":"Krause","year":"2023"},{"key":"2023111521055128000_jiad354-B28","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1097\/MS9.0000000000000596","article-title":"A reflection on the Marburg virus outbreak in Tanzania: the importance of preparedness and prevention in public health\u2014a correspondence","volume":"85","author":"Aderinto","year":"2023","journal-title":"Ann Med Surg (Lond)"},{"key":"2023111521055128000_jiad354-B29","doi-asserted-by":"crossref","first-page":"100038","DOI":"10.1016\/j.infpip.2020.100038","article-title":"The 2018\/19 Ebola epidemic the Democratic Republic of the Congo (DRC): epidemiology, outbreak control, and conflict","volume":"2","author":"Shears","year":"2020","journal-title":"Infect Prev Pract"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiad354\/51173618\/jiad354.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/Supplement_7\/S474\/53451821\/jiad354.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/228\/Supplement_7\/S474\/53451821\/jiad354.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,26]],"date-time":"2024-10-26T07:48:31Z","timestamp":1729928911000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/228\/Supplement_7\/S474\/7246203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,19]]},"references-count":29,"journal-issue":{"issue":"Supplement_7","published-online":{"date-parts":[[2023,8,19]]},"published-print":{"date-parts":[[2023,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiad354","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11,15]]},"published":{"date-parts":[[2023,8,19]]}}}